Germany-based Bayer Schering Pharma AG will establish a US Innovation Center in San Francisco, as it moves to expand its global research network and build its speciality pharmaceutical pipeline. The model introduces a newly formed 'Science Hub' for innovation sourcing in the US creating collaborations with academic research scientists and jimall biotech firms to realise product development and commercialisation of new therapies through partnerships with Bayer.
展开▼
